Abstract
Fab fragments are valuable research tools in various areas of science including applications in imaging, binding studies, removal of Fc-mediated effector functions, mass spectrometry, infection biology, and many others. The enzymatic tools for the generation of Fab fragments have been discovered through basic research within the field of molecular bacterial pathogenesis. Today, these enzymes are widely applied as research tools and in this chapter, we describe methodologies based on bacterial enzymes to generate Fab fragments from both human and mouse IgG. For all human IgG subclasses, the IdeS enzyme from Streptococcus pyogenes has been applied to generate F(ab′)2 fragments that subsequently can be reduced under mild conditions to generate a homogenous pool of Fab′ fragments. The enzyme Kgp from Porphyromonas gingivalis has been applied to generate intact Fab fragments from human IgG1 and the Fab fragments can be purified using a CH1-specific affinity resin. The SpeB protease, also from S. pyogenes, is able to digest mouse IgGs and has been applied to digest antibodies and Fab fragments can be purified on light chain affinity resins. In this chapter, we describe methodologies that can be used to obtain Fab fragments from human and mouse IgG using bacterial proteases.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Liu H, May K (2012) Disulfide bond structures of IgG molecules: structural variations, chemical modifications and possible impacts to stability and biological function. MAbs 4:17–23
Sjögren J, Collin M (2014) Bacterial glycosidases in pathogenesis and glycoengineering. Future Microbiol 9:1039–1051
Collin M, Olsén A (2003) Extracellular enzymes with immunomodulating activities: variations on a theme in Streptococcus pyogenes. Infect Immun 71:2983–2992
Walker MJ, Barnett TC, Mcarthur JD et al (2014) Disease manifestations and pathogenic mechanisms of group a Streptococcus. Clin Microbiol Rev 27:264–301
Nizet V (2007) Understanding how leading bacterial pathogens subvert innate immunity to reveal novel therapeutic targets. J Allergy Clin Immunol 120:13
von Pawel-Rammingen U, Johansson BP, Björck L (2002) IdeS, a novel streptococcal cysteine proteinase with unique specificity for immunoglobulin G. EMBO J 21:1607–1615
Abe N, Kadowaki T, Okamoto K et al (1998) Biochemical and functional properties of lysine-specific cysteine proteinase (Lys-gingipain) as a virulence factor of Porphyromonas gingivalis in periodontal disease. J Biochem 123:305–312
Collin M, Olsén A (2001) Effect of SpeB and EndoS from Streptococcus pyogenes on human immunoglobulins. Infect Immun 69:7187–7189
Vincents B, von Pawel-Rammingen U, Björck L et al (2004) Enzymatic characterization of the streptococcal endopeptidase, IdeS, reveals that it is a cysteine protease with strict specificity for IgG cleavage due to exosite binding. Biochemistry 43:15540–15549
Sjögren J, Olsson F, Beck A (2016) Rapid and improved characterization of therapeutic antibodies and antibody related products using IdeS digestion and subunit analysis, The Analyst 141(11):3114–3125
An Y, Zhang Y, Mueller H-M et al (2014) A new tool for monoclonal antibody analysis: application of IdeS proteolysis in IgG domain-specific characterization. MAbs 6:879–893
Beck A, Debaene F, Diemer H et al (2015) Cutting-edge mass spectrometry characterization of originator, biosimilar and biobetter antibodies. J Mass Spectrom 50:285–297
Beck A, Terral G, Debaene F et al (2016) Cutting-edge mass spectrometry methods for the multi-level structural characterization of antibody-drug conjugates. Expert Rev Proteomics 13:157–183
Johansson BP, Shannon O, Björck L (2008) IdeS: a bacterial proteolytic enzyme with therapeutic potential. PLoS One 3:e1692
Winstedt L, Järnum S, Nordahl EA et al (2015) Complete removal of extracellular IgG antibodies in a randomized dose-escalation phase I study with the bacterial enzyme IdeS - a novel therapeutic opportunity. PLoS One 10:e0132011
Mysak J, Podzimek S, Sommerova P et al (2014) Porphyromonas gingivalis: major periodontopathic pathogen overview. J Immunol Res 2014:1–8
Vincents B, Guentsch A, Kostolowska D et al (2011) Cleavage of IgG1 and IgG3 by gingipain K from Porphyromonas gingivalis may compromise host defense in progressive periodontitis. FASEB J 25:3741–3750
de Diego I, Veillard F, Sztukowska MN et al (2014) Structure and mechanism of cysteine peptidase gingipain K (Kgp), a major virulence factor of Porphyromonas gingivalis in periodontitis. J Biol Chem 289:32291–32302
Shen A, Bogyo M (2012) Chapter 523 Gingipain K, Elsevier Ltd. Handbook of Proteolytic Enzymes, (2012) 2337-2344. doi:10.1016/B978-0-12-382219-2.00521-4
Elliott SD (1945) A proteolytic enzyme produced by group A streptococci with special reference to its effect on the type-specific m antigen. J Exp Med 81:573–592
Elliott SD (1950) The crystallization and serological differentiation of a streptococcal proteinase and its precursor. J Exp Med 92:201–218
Olsson F, Norgren M, Mejare M et al (2013) Initial characterization of a recombinantly modified SpeB from Streptococcus pyogenes for antibody subunit domain generation. Poster presented at CASSS Mass Spectrometry Conference, Boston, MA, USA
Persson H, Vindebro R, von Pawel-Rammingen U (2013) The streptococcal cysteine protease SpeB is not a natural immunoglobulin-cleaving enzyme. Infect Immun 81:2236–2241
Collin M, Svensson MD, Sjöholm AG et al (2002) EndoS and SpeB from Streptococcus pyogenes inhibit immunoglobulin-mediated opsonophagocytosis. Infect Immun 70:6646–6651
Nelson DC, Garbe J, Collin M (2011) Cysteine proteinase SpeB from Streptococcus pyogenes - a potent modifier of immunologically important host and bacterial proteins. Biol Chem 392:1077–1088
Eriksson A, Norgren M (2003) Cleavage of antigen-bound immunoglobulin G by SpeB contributes to streptococcal persistence in opsonizing blood. Infect Immun 71:211–217
Singh R, Whitesides GM (1993) Thiol—disulfide interchange. In: Patai S, Rappoport Z (eds) Sulphur-containing functional groups (1993). John Wiley & Sons, Inc., Chichester, UK
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media New York
About this protocol
Cite this protocol
Sjögren, J., Andersson, L., Mejàre, M., Olsson, F. (2017). Generating and Purifying Fab Fragments from Human and Mouse IgG Using the Bacterial Enzymes IdeS, SpeB and Kgp. In: Nordenfelt, P., Collin, M. (eds) Bacterial Pathogenesis. Methods in Molecular Biology, vol 1535. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6673-8_21
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6673-8_21
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-6671-4
Online ISBN: 978-1-4939-6673-8
eBook Packages: Springer Protocols